Your browser doesn't support javascript.
loading
Rapid detection of colistin resistance protein MCR-1 by LC-MS/MS.
Wang, Honghui; Chen, Yong; Strich, Jeffrey R; Drake, Steven K; Youn, Jung-Ho; Rosenberg, Avi Z; Gucek, Marjan; McGann, Patrick T; Suffredini, Anthony F; Dekker, John P.
Afiliação
  • Wang H; 1Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD USA.
  • Chen Y; 2Proteomics Core Facility, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD USA.
  • Strich JR; 1Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD USA.
  • Drake SK; 1Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD USA.
  • Youn JH; 3Department of Laboratory Medicine, Clinical Center, Microbiology Service, National Institutes of Health, 10 Center Drive, Bethesda, MD USA.
  • Rosenberg AZ; 4Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD USA.
  • Gucek M; 5Department of Pathology, Johns Hopkins University, Baltimore, MD USA.
  • McGann PT; 2Proteomics Core Facility, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD USA.
  • Suffredini AF; 6Walter Reed Army Institute of Research, Silver Spring, MD USA.
  • Dekker JP; 1Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD USA.
Clin Proteomics ; 16: 8, 2019.
Article em En | MEDLINE | ID: mdl-30890899
ABSTRACT

BACKGROUND:

Colistin (polymyxin E) and polymixin B are important bactericidal antibiotics used in the treatment of serious infections caused by multi-drug resistant Gram-negative organisms. Transferrable plasmid-mediated colistin resistance, conferred by the product of the mcr-1 gene, has emerged as a global healthcare threat. Consequently, the rapid detection of the MCR-1 protein in clinical bacterial isolates has become increasingly important. We used a genoproteomic approach to identify unique peptides of the MCR-1 protein that could be detected rapidly by liquid chromatography tandem mass spectrometry (LC-MS/MS).

METHODS:

MCR-1 tryptic peptides that were efficiently ionized and readily detectable were characterized in a set of mcr-1-containing isolates with triple quadrupole LC-MS. Three optimal peptides were selected for the development of a rapid multiple reaction monitoring LC-MS/MS assay for the MCR-1 protein. To investigate the feasibility of rapid detection of the MCR-1 protein in bacterial isolates using this assay, a blinded 99-sample test set was built that included three additional mcr-1-containing clinical isolates tested in triplicate (9 samples) and 90 negative control isolates.

RESULTS:

All of the mcr-1-containing isolates in the test set were accurately identified with no false positive detections by three independent, blinded operators, yielding an overall performance of 100% sensitivity and specificity for multiple operators. Among the three peptides tested in this study, the best performing was DTFPQLAK. The isolate-to-result time for the assay as implemented is less than 90 min.

CONCLUSIONS:

This work demonstrates the feasibility of rapid detection of the MCR-1 protein in bacterial isolates by LC-MS/MS.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article